SeNostic Health

The SeNostic GmbH is installed in Hannover's Medical Park, Germany. The company was founded in 2014 in Braunschweig by Dr. Thorsten Lührs and Dr. Christiane Ritter. SeNostic develops its proprietary SeedCycler® Technology platform for the precise and accurate early differential diagnosis of neurodegenerative disorders, including Alzheimer's disease or Parkinson's disease. The analysis process of SeNostic provides a unique way to amplify disease-specific protein aggregates (Seed-Biomarkers) present in tissues and body fluids. These are characteristic for pathological disease processes, and increase over disease progression. The potential for nearly error-free in vitro diagnostics, which especially avoids false-positive results, has a world-wide market potential for today's clinical diagnostics, for future preclinical diagnostics and for the stratification and follow-up of pharmaceutical clinical trials. SeNostic also produces high-quality recombinant proteins that are involved in neurodegenerative disorders. These can be purchased for research use via SeNositc's web-site.